Aspirin therapy is an essential part of the drug regimen for patients with
acute myocardial infarction (MI), unstable angina, or after coronary angiop
lasty and coronary stenting. Recognizing this importance, this study sought
to compare the bleeding time in two groups of 10 normal volunteers 4 hr af
ter ingestion of either an enteric-coated aspirin or an uncoated aspirin, a
ssuming that a difference between the two groups could be clinically signif
icant. Defining less than or equal to 8 min as normal, 80% of the uncoated
group developed abnormal bleeding times, compared to 10% of the enteric-coa
ted group (P < 0.01). The study demonstrates a significant difference betwe
en the two types of aspirin preparations on bleeding times in normal indivi
duals. This strongly suggests that some enteric-coated aspirin preparations
may not be as effective as uncoated aspirin in acutely decreasing platelet
aggregation. Therefore, uncoated aspirin is recommended in the setting of
acute MI, unstable angina, or after percutaneous transluminal coronary angi
oplasty. Cathet, Cardiovasc. Diagn. 45:396-399, 1998. (C) 1998 Wiley-Liss,
Inc.